Hypertension, hyperlipidemia
Conditions
Interventions
Sponsors
Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Aged between 18 and 65 years, regardless of gender; (2) The body mass index is between 18.5-23.9kg/m2; (3) No abnormal blood pressure (systolic blood pressure <120mmHg, diastolic blood pressure <80mmHg); (4) Did not take any medicine for nearly 4 weeks; (5) There is no major disease in the past; (6) Subjects gave informed consent and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with hypertension; (2) Those with previous history of hyperlipidemia and cardiovascular and cerebrovascular diseases; (3) Active ulcers and bleeding tendency, long-term use of anticoagulant, antiplatelet drugs; (4) Those who are taking antihypertensive and lipid-lowering drugs; (5) Those with severe heart, lung, liver and kidney dysfunction and nervous system diseases; (6) Other diseases or mental illnesses that the investigator believes may limit efficacy evaluation or patient follow-up; (7) Patients who have participated in other drug clinical trials in the past 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure;Renin;Angiotensin II; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fibrinogen;Triglyceride;Total cholesterol;Fasting blood sugar;Partial thromboplastin time;Thrombin time;Low density lipoprotein cholesterol;Prothrombin time;Transcriptomics;High density lipoprotein cholesterol;Platelet function test;Genomics; | — |
Countries
China
Contacts
Public ContactShengxian Wu
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed